Net Cash Provided by (Used in) Financing Activities in USD of ReShape Lifesciences Inc. from 2014 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ReShape Lifesciences Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2014 to Q1 2025.
  • ReShape Lifesciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $3.95M.
  • ReShape Lifesciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $677K, a 96.1% decline from 2023.
  • ReShape Lifesciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $17.6M, a 461% increase from 2022.
  • ReShape Lifesciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.13M, a 90.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ReShape Lifesciences Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $3.95M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-20
Q1 2023 $10.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2021 $1M +$1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q1 2020 $0 -$10.6M -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $10.6M +$10.6M +37786% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-19
Q1 2018 $28K +$28K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $0 -$2K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $2K* Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10

ReShape Lifesciences Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $677K -$16.9M -96.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-04
2023 $17.6M +$14.4M +461% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-04
2022 $3.13M -$30.2M -90.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $33.3M +$22.2M +201% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $11.1M -$2.3M -17.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 $13.4M +$3.38M +33.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $9.99M +$9.38M +1530% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $613K -$82.2M -99.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-22
2016 $82.8M +$77.7M +1535% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-05
2015 $5.06M -$17.1M -77.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 $22.2M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.